BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 11 filers reported holding BAXTER INTL INC in Q4 2011. The put-call ratio across all filers is - and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,465,655 | -16.1% | 171,321 | +1.3% | 0.03% | -14.7% |
| Q2 2023 | $7,702,146 | +32.6% | 169,055 | +18.0% | 0.03% | +21.4% |
| Q1 2023 | $5,809,003 | -33.6% | 143,220 | -16.5% | 0.03% | -40.4% |
| Q4 2022 | $8,747,013 | -36.6% | 171,611 | -33.0% | 0.05% | -42.7% |
| Q3 2022 | $13,787,000 | -20.2% | 255,981 | -4.8% | 0.08% | -18.8% |
| Q2 2022 | $17,277,000 | -16.6% | 268,988 | +0.7% | 0.10% | -1.0% |
| Q1 2022 | $20,716,000 | -6.5% | 267,167 | +3.5% | 0.10% | -4.7% |
| Q4 2021 | $22,153,000 | -3.4% | 258,073 | -9.5% | 0.11% | -13.7% |
| Q3 2021 | $22,942,000 | +126.0% | 285,240 | +126.2% | 0.12% | +121.4% |
| Q2 2021 | $10,150,000 | +1.9% | 126,085 | +6.8% | 0.06% | -5.1% |
| Q1 2021 | $9,959,000 | +5.2% | 118,085 | +0.0% | 0.06% | +1.7% |
| Q4 2020 | $9,471,000 | -13.1% | 118,033 | -12.9% | 0.06% | -24.7% |
| Q3 2020 | $10,904,000 | -6.1% | 135,586 | +0.6% | 0.08% | -23.0% |
| Q2 2020 | $11,607,000 | +9.9% | 134,811 | +3.7% | 0.10% | +1.0% |
| Q1 2020 | $10,558,000 | -44.9% | 130,036 | -43.3% | 0.10% | -33.1% |
| Q4 2019 | $19,167,000 | -24.9% | 229,216 | -21.5% | 0.15% | -30.8% |
| Q3 2019 | $25,538,000 | +1.9% | 291,966 | -4.6% | 0.21% | +0.5% |
| Q2 2019 | $25,054,000 | -4.6% | 305,905 | -5.2% | 0.21% | -9.4% |
| Q1 2019 | $26,249,000 | +104.1% | 322,822 | +65.2% | 0.24% | +82.2% |
| Q4 2018 | $12,863,000 | -41.1% | 195,428 | -31.0% | 0.13% | -30.3% |
| Q3 2018 | $21,843,000 | -6.7% | 283,338 | -10.7% | 0.18% | -11.5% |
| Q2 2018 | $23,419,000 | +16.2% | 317,157 | +2.3% | 0.21% | +14.2% |
| Q1 2018 | $20,156,000 | -3.4% | 309,901 | -4.0% | 0.18% | -1.1% |
| Q4 2017 | $20,862,000 | +18.2% | 322,748 | +14.8% | 0.18% | +12.8% |
| Q3 2017 | $17,643,000 | +13.0% | 281,156 | +9.0% | 0.16% | +6.5% |
| Q2 2017 | $15,610,000 | +18.5% | 257,853 | +1.5% | 0.15% | +18.5% |
| Q1 2017 | $13,168,000 | +24.6% | 253,918 | +6.5% | 0.13% | +19.3% |
| Q4 2016 | $10,570,000 | +61.5% | 238,376 | +73.4% | 0.11% | +60.3% |
| Q3 2016 | $6,544,000 | +85.0% | 137,480 | +75.8% | 0.07% | +47.8% |
| Q2 2016 | $3,537,000 | -43.4% | 78,224 | -48.6% | 0.05% | -41.8% |
| Q1 2016 | $6,249,000 | +93.3% | 152,122 | +79.5% | 0.08% | +92.7% |
| Q4 2015 | $3,233,000 | +10.4% | 84,750 | -4.9% | 0.04% | 0.0% |
| Q3 2015 | $2,928,000 | -49.9% | 89,140 | +6.7% | 0.04% | -49.4% |
| Q2 2015 | $5,842,000 | -2.2% | 83,545 | -4.2% | 0.08% | -2.4% |
| Q1 2015 | $5,973,000 | -16.3% | 87,200 | -10.5% | 0.08% | -62.1% |
| Q4 2014 | $7,138,000 | +131.2% | 97,389 | +126.4% | 0.22% | +116.8% |
| Q3 2014 | $3,088,000 | -62.2% | 43,024 | -61.9% | 0.10% | -57.9% |
| Q2 2014 | $8,172,000 | +0.9% | 113,024 | +2.6% | 0.24% | -4.0% |
| Q1 2014 | $8,103,000 | +2.1% | 110,115 | -3.5% | 0.25% | -3.8% |
| Q4 2013 | $7,938,000 | +35.6% | 114,123 | +28.1% | 0.26% | +28.7% |
| Q3 2013 | $5,854,000 | -12.4% | 89,113 | -7.6% | 0.20% | -13.3% |
| Q2 2013 | $6,680,000 | +32.4% | 96,443 | +38.8% | 0.23% | +31.6% |
| Q1 2013 | $5,047,000 | +12.6% | 69,478 | +3.3% | 0.18% | +0.6% |
| Q4 2012 | $4,483,000 | -3.8% | 67,253 | -13.1% | 0.18% | -6.9% |
| Q3 2012 | $4,662,000 | -20.1% | 77,362 | -29.5% | 0.19% | -27.6% |
| Q2 2012 | $5,832,000 | -36.5% | 109,716 | -28.6% | 0.26% | -37.0% |
| Q1 2012 | $9,185,000 | +61.5% | 153,650 | +33.7% | 0.41% | +59.2% |
| Q4 2011 | $5,687,000 | – | 114,919 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |